Sangamo Exec Gary Lee Joins Senti Bio as Chief Scientific Officer

Xconomy San Francisco — 

Senti Biosciences has appointed Gary Lee to serve as chief scientific officer. Lee comes to the South San Francisco, CA, biotech from Sangamo Therapeutics (NASDAQ: SGMO), where he was vice president of cell therapy. Senti emerged in February with $53 million in Series A financing to support its cell therapy research.